DWS Group GmbH & Co. KGaA (ETR:DWS)
55.20
+0.40 (0.73%)
Aug 8, 2025, 5:35 PM CET
Revance Therapeutics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.